175
Views
7
CrossRef citations to date
0
Altmetric
Original Research Article

Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara®, over three medication cycles

, , &
Pages 39-48 | Published online: 06 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Robin Kroll, Larry Seidman, Nancy Ricciotti, Brandon Howard & Herman Weiss. (2015) A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. The European Journal of Contraception & Reproductive Health Care 20:4, pages 249-258.
Read now
Serena Ferrari, Marianna Cannoletta, Matteo Generali, Lucia Cazzato & Angelo Cagnacci. (2010) Efficacy, safety, and patient acceptability of the combined chlormadinone acetate-ethinylestradiol oral contraceptive. Open Access Journal of Contraception 1, pages 93-101.
Read now

Articles from other publishers (5)

Jan Endrikat, Susanne Parke, Dietmar Trummer, Marco Serrani, Ingrid Duijkers & Christine Klipping. (2013) Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study. Contraception 87:2, pages 227-234.
Crossref
Jürgen Spona, Natascha Binder, Kornelia Höschen & Wilfried Feichtinger. (2010) Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles. Fertility and Sterility 94:4, pages 1195-1201.
Crossref
Cristina Lopez-del Burgo, Carmen Marina Lopez-de Fez, Alfonso Osorio, José Lopez Guzmán & Jokin de Irala. (2010) Spanish women's attitudes towards post-fertilization effects of birth control methods. European Journal of Obstetrics & Gynecology and Reproductive Biology 151:1, pages 56-61.
Crossref
Sabine Anthuber, Georg A.K. Schramm & Marie-Luise S. Heskamp. (2010) Six-Month Evaluation of the Benefits of the Low-Dose Combined Oral Contraceptive Chlormadinone Acetate 2 mg/Ethinylestradiol 0.03 mg in Young Women. Clinical Drug Investigation 30:4, pages 211-220.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.